Dr Reddys Laboratories Ltd.
| BSE: 500124 | Sector: Health care |
| NSE: DRREDDY | ISIN Code: INE089A01023 |
| BSE 00:00 | 11 May | 5293.60 |
-35.50 (-0.67%) |
OPEN
5329.10 |
HIGH
5349.85 |
LOW
5272.00 |
| NSE 00:00 | 11 May | 5295.95 |
-31.60 (-0.59%) |
OPEN
5325.00 |
HIGH
5349.95 |
LOW
5271.30 |
| OPEN | 5329.10 |
| PREVIOUS CLOSE | 5329.10 |
| VOLUME | 61728 |
| 52-Week high | 5514.65 |
| 52-Week low | 3613.45 |
| P/E | 37.02 |
| Mkt Cap.(Rs cr) | 88,033 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Dr Reddys Laboratories Ltd. (DRREDDY) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Sun Pharma.Inds. | 707.85 | 9.70 | 1.39 | 3211.14 |
| Dr Reddy's Labs | 5293.60 | -35.50 | -0.67 | 2937.70 |
| Cipla | 890.75 | -9.50 | -1.06 | 2318.17 |
| Aurobindo Pharma | 1030.80 | -16.80 | -1.60 | 1872.74 |
| Cadila Health. | 629.70 | 5.70 | 0.91 | 1412.90 |
| Divi's Lab. | 4074.65 | -62.40 | -1.51 | 1372.71 |
| Glenmark Pharma. | 624.55 | -1.10 | -0.18 | 1354.55 |
| Alkem Lab | 3032.35 | 2.70 | 0.09 | 1264.42 |
| Alembic Pharma | 952.75 | -6.70 | -0.70 | 969.40 |
| Torrent Pharma. | 2714.90 | -51.55 | -1.86 | 938.51 |
| Gland Pharma | 2866.15 | 72.05 | 2.58 | 772.86 |
| Lupin | 1197.60 | -25.20 | -2.06 | 727.55 |
| Ipca Labs. | 2160.20 | 74.95 | 3.59 | 652.46 |
| Abbott India | 16193.55 | 91.10 | 0.57 | 592.93 |
| Fortis Health. | 236.15 | 1.85 | 0.79 | 513.33 |
| Pfizer | 5401.70 | 15.10 | 0.28 | 509.13 |
| Sanofi India | 7853.35 | 56.60 | 0.73 | 477.60 |
| Natco Pharma | 927.15 | -14.25 | -1.51 | 474.50 |
| Apollo Hospitals | 3259.30 | -66.10 | -1.99 | 470.30 |
| Granules India | 359.90 | -4.25 | -1.17 | 444.07 |
Quick Links for Dr Reddys Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
